Login


Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?

Paduda: Work Comp Payers and COVID Legislation Funding

By Joe Paduda

Monday, April 4, 2022 | 0

You may have noticed President Biden’s request for $15 billion in additional funds to cover vaccines, antivirals and other COVID-related needs failed.

Joe Paduda

Joe Paduda

Fortunately, it’s back on the table.

Unfortunately, part of the funding may come from work comp payers.

The latest news out of Capitol Hill is that there appears to be agreement on a $10 billion COVID care funding bill. While that’s a lot less than the $2 billion the Feds are spending each month for vaccines, treatment and related expenses, it’s a whole shipload better than nothing.

The workers’ comp angle appears to be a response to Republican concerns over where to find the funds; while some (amount to be determined) dollars will come from unspent stimulus funds, there’s an unknown gap, and Republicans will not approve the new bill unless funding is guaranteed and is not “new” spending.

Enter over-reserved and super-profitable workers’ comp. The industry’s stellar underwriting margins during the COVID era make it one of the select few sectors that thrived during the pandemic. That, and the sense among some that the inconsistent way states dealt with presumption reduced the comp insurance industry’s costs make comp an attractive target.

From Yahoo, Senate Minority Leader Mitch McConnell, R-Ky., said Tuesday:

“My view is that it ought to be entirely paid for out of money that’s already in the pipeline by reprogramming it for whatever amount they can justify to get the job done.”

Except it looks like COVID funding will be fully utilized.

There’s this from Sen. John Thune, R-South Dakota, in The Hill:

“I don’t think the Dems would agree to offsets that would allow them to cover that. So it’s dropped down to the size that they were willing to pay for.

“That $5 billion piece could be easily part of the package, but they are just reluctant to repurpose funds, and there’s a whole pile of them sitting out there,” he added.

Side note: A lot of people are about to lose health coverage as the COVID-era Medicaid funding supplement is about to expire, leaving those people uninsured (continuing Medicaid funding could have helped make up any shortfall).

The Dems want to keep the global vaccine program funded, while Republicans don’t want to spend.

More from The Hill:

Romney and Schumer have been swapping offers on a list of potential ways to pay for a deal throughout the week, with Republicans arguing there is more than enough to cover a bill for the full $15.6 billion.

How work comp got into the conversation is anyone’s guess. Here’s my speculation:

  • Initial research indicated work comp might have to spend billions on COVID care; that turned out to be wildly overstated (of course, researchers had very little information to go on).
  • Congress’ budget folks likely saw the reports and know the industry spent a small fraction of the “potential” costs.
  • Work comp is outside federal funding or federal responsibility. Politically, it’s easy to spend dollars from someone else’s wallet.
  • The massive profits earned by work comp payers, plus the industry’s $14 billion in “excess” reserves, make this a very attractive target. 

Rep. Tom Malinowski, D-New Jersey, from Politico:

“I just cannot support another round of COVID funding that just completely eviscerates our ability to be, as Joe Biden put it, the arsenal of vaccines for the world. We have to get it right.”

So, we have:

  • Politicians looking to have something positive to say when they head home for the Easter break.
  • Another potential COVID wave on the way.
  • A major funding gap.
  • A super-profitable, wildly over-reserved insurance sector with little to no sway on Capitol Hill.

How this works out, if it does, is also anyone’s guess.

What does this mean for you?

As the old lobbyist says: “If you aren’t at the table, you’re on the menu.”

Joseph Paduda is co-owner of CompPharma, a consulting firm focused on improving pharmacy programs in workers’ compensation. This column is republished with his permission from his Managed Care Matters blog.

Comments

Related Articles